Clinical trial
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
NCT00454103 · University of Wuerzburg, Other · Completed
Key facts
| NCT number | NCT00454103 |
|---|---|
| Title | Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy |
| Lead sponsor | University of Wuerzburg, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Adrenal Tumor, Adrenocortical Carcinoma |
| Intervention type | Drug |
| Interventions | 123I-Iodometomidate |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Mar 30, 2007 |
| Last update posted | Aug 18, 2010 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: